Institutional documents and regulatory signals traced to source, keeping official text separate from potential operational implications.
The guidance applies to submissions filed from 20 July 2026 and makes the connection between characterisation, proposed use and exposure more explicit.
Read the analysis →The opinion defines the evaluated form, population and use level, providing a concrete regulatory reference for new choline-source development.
Read the analysis →The producer strain could not be conclusively assigned to a species, preventing completion of the Novel Food safety assessment.
Read the analysis →Inclusion of a plant directs documentary research but does not by itself establish that every extract, dose or product is hazardous.
Read the analysis →The work covers new forms, metabolites and molecules with vitamin activity intended for supplements, fortified foods and specific population groups.
Read the analysis →Priorities include Huperzia serrata, guggul, Coleus forskohlii, ginseng, black radish, emodin, chrysophanol and selected Bifidobacterium strains.
Read the analysis →Machine learning and data-driven models can accelerate screening, mechanism interpretation, data integration and optimisation, but depend on experimental quality.
Read the analysis →The Novel Food is proposed for supplements at up to 203.7 mg per day, equivalent to 82.5 mg choline, for people over three years of age.
Read the analysis →Commercial value depends on continuity between the studied strain and the strain that is actually manufactured, stabilised, dosed and communicated.
Read the analysis →The caffeine-free botanical complex is positioned for energy, focus and mood applications, with dsm-firmenich supporting clinical, regulatory and commercial development.
Read the analysis →The project combines nutrivigilance, reports and botanical screening to identify priorities for further investigation, not an automatic list of prohibited ingredients.
Read the analysis →Combining diet, biomarkers, multi-omics, microbiome and wearables is not enough: models must generalise and show value in real populations and settings.
Read the analysis →Six ingredients or ingredient groups and three botanical substances are identified as signals requiring further investigation, not as risks that have already been conclusively established.
Read the analysis →Age, education, urbanisation and dietary composition change the footprint of diets; targeted interventions may be more informative than uniform approaches.
Read the analysis →Anonymous product purchasing reduces the risk that certification reflects only manufacturer-selected samples and makes product quality more legible to buyers.
Read the analysis →Topic pages connect current reporting with the permanent archive.
Receive the editorial selection or request a free introductory conversation on using AI tools and automation in nutraceutical work.
GMA